TY  - JOUR
T1  - AUreomycin therapy in human brucellosis due to brucella abortus
AU  - BRAUDE AI, HALL WH, SPINK WW
Y1  - 1949/11/19
N1  - 10.1001/jama.1949.02910120019005
JO  - Journal of the American Medical Association
SP  - 831
EP  - 835
VL  - 141
IS  - 12
N2  - In a previous study conducted in México, D. F., aureomycin was found to produce more satisfactory immediate results than any other specific therapy in the treatment of brucellosis due to Brucella melitensis.1 These results were characterized by prompt clinical improvement, sterilization of the blood and absence of serious side effects. A second group of patients, in whom the infection was caused by Brucella abortus, were treated successfully with aureomycin in Minneapolis, and the present report describes the effect of aureomycin in these 16 patients with bacteriologically proved brucellosis.METHODS OF STUDY 
    Aureomycin was administered orallyto 16 consecutive patients from whose blood Br. abortus was isolated by culture (table 1). In every case the severity of symptoms necessitated hospitalization. In 7 patients the duration of symptoms was less than two months. These 7 patients were considered to have acute infections. In the remaining 8 patients the symptoms were present longer
SN  - 0002-9955
M3  - doi: 10.1001/jama.1949.02910120019005
UR  - http://dx.doi.org/10.1001/jama.1949.02910120019005
ER  -